Why Delivery Method Matters for AKG Supplements

In dietary supplementation, finding an effective ingredient is only half the battle. The other half—often the more challenging part—is ensuring that the nutrient reaches the cells where it is needed. When a compound is swallowed, it must pass through stomach acid, survive digestive enzymes, cross the gut wall, and avoid rapid clearance by the liver and kidneys. If a molecule breaks down too early, even large doses will produce minimal real-world benefit.

Over the past decade, the wellness industry has embraced advanced delivery systems to address this issue. Two of the most common technologies are enteric coatings and liposomal encapsulation. Both are widely used across pharmaceuticals and nutraceuticals, and both are often marketed as universal solutions for poor absorption.

When applied to alpha-ketoglutarate, or AKG, each delivery technology produces very different physiological outcomes.

At Rejuvant, our science team works closely with Chief Scientific Officer Dr. Brian Kennedy to study how metabolic intermediates behave in the human body. Alpha-ketoglutarate is an essential molecule that sits at the center of energy production, amino acid balance, and epigenetic regulation. However, AKG presents a unique set of biochemical hurdles that standard delivery technologies fail to resolve.

Examining how enteric coatings, liposomes, and controlled-release CaAKG interact with human digestion explains why delivery design dictates biological success.

To understand why delivery matters, we first have to examine how the body processes unformulated alpha-ketoglutarate.

Alpha-ketoglutarate is a naturally occurring intermediate in the citric acid cycle, also known as the Krebs cycle. Inside your mitochondria, it helps generate cellular energy in the form of ATP, facilitates nitrogen transport, and acts as an essential cofactor for enzymes that maintain DNA methylation. Despite these vital roles, oral intake of raw AKG encounters three major physiological obstacles:

Because of these hurdles, simply swallowing a standard capsule of raw AKG does not raise systemic levels in a sustained way. This has led researchers to explore whether enteric coatings or liposomes can protect the molecule.

Enteric coatings are polymers applied to the outer surface of a tablet or capsule. They are designed to remain intact in acidic environments, such as the stomach, where the pH ranges from 1.5 to 3.5. Once the capsule moves into the small intestine, where the environment becomes more alkaline (pH above 5.5), the coating dissolves and releases its contents.

Enteric coatings are useful for protecting drugs that degrade in stomach acid, or for preventing stomach irritation caused by certain compounds. When applied to AKG, however, this approach runs directly into the intestinal clearance problem.

An enteric coating does protect the capsule during its passage through the stomach. But once the capsule enters the duodenum—the upper portion of the small intestine—the coating dissolves completely, releasing the entire payload of raw AKG at once.

This rapid release dumps the active nutrient directly into the area with the highest concentration of enterocytes. Because these gut cells consume AKG on contact, they absorb and metabolize the vast majority of the dose right away. Instead of entering the bloodstream as active AKG, the compound is rapidly converted into glutamate and other breakdown products.

This creates a brief spike in plasma glutamate, while systemic AKG levels remain largely unchanged. Because the molecule still faces its five-minute half-life, the portion that escapes into the blood is cleared almost immediately.

This explains why our 2026 real-world cohort study in Aging Cell, which evaluated 4,260 health-conscious adults, found that standard, non-delayed AKG showed no statistically significant association with lower biological age. Enteric coatings shield the molecule from acid, but they release it in the worst possible location for long-term systemic absorption.

Liposomal encapsulation takes a different scientific path. In this approach, active molecules are trapped inside microscopic spheres made of lipid bilayers, similar to the membranes of human cells.

Liposomal delivery is engineered primarily to solve membrane transport issues. Because AKG is a charged weak acid that struggles to diffuse across cell membranes, wrapping it in a fatty envelope allows the liposome to fuse with cell surfaces. This facilitates direct entry into the cell interior.

While liposomes address membrane transport, they fail to resolve the core pharmacokinetic clearance problem.

When you ingest a liposomal supplement, the lipid spheres pass through the stomach and are taken up by intestinal cells or absorbed into the lymphatic system and portal vein. Once inside circulation, the liposomes release their payload.

At that point, the released AKG is once again free, unshielded acid. It remains entirely subject to its native five-minute half-life. Standard oral liposomes do not maintain a prolonged, multi-hour release profile in the blood. They provide a temporary increase in cellular uptake, but the molecule is cleared by hepatic and renal pathways before it can provide continuous enzymatic support across distant tissues.

Furthermore, liposomal AKG lacks validation in human clinical trials measuring biological aging clocks. While liposomes are useful for fat-soluble vitamins or unstable botanicals, they do not solve the rapid clearance rate that defines small metabolic intermediates like AKG.

The formulation used in Rejuvant addresses both the physical stability of the molecule and the digestive clearance rate through a dual-action design:

This controlled-release profile changes how the gut handles the nutrient. By releasing small amounts of CaAKG continuously over several hours, the tablet avoids overwhelming the gut with a sudden surplus. Local enterocytes absorb what they need for energy, and the remainder passes safely across the intestinal wall into the portal vein.

Because the release is sustained, a steady concentration of active CaAKG enters systemic circulation over an extended period. This prolonged presence overcomes the five-minute half-life hurdle, maintaining elevated plasma levels long enough to reach peripheral tissues.

Maintaining a continuous supply of CaAKG in the bloodstream is essential because the cellular targets that regulate biological aging require ongoing metabolic support.

One of the primary roles of systemic AKG is serving as an obligatory cofactor for a family of enzymes called 2-oxoglutarate-dependent dioxygenases (2-OGDDs). This family includes TET DNA demethylases and JmjC histone demethylases. These enzymes maintain the structure of your genome by removing excess chemical tags from DNA, helping cells preserve a youthful pattern of gene expression. Because these enzymes continuously process DNA, they need a steady supply of their cofactor rather than a brief five-minute spike.

A sustained supply of CaAKG is equally important for cellular antioxidant defense. Through enzymatic transamination, AKG is converted into glutamate and glutamine, which are the essential building blocks for glutathione—the body’s master cellular antioxidant. In red blood cells, which lack the transport channels to take in glutamate directly from the blood, absorbing circulating AKG provides the backdoor fuel needed to synthesize glutathione and protect blood cells from oxidative stress.

This steady delivery explains the real-world results observed in our published research. In the 2026 Aging Cell study, controlled-release CaAKG was the standout compound associated with a 1.8-year lower biological Age Residual (p < 0.01) across 4,260 adults, while standard, unformulated AKG showed no statistically significant effect.

Evaluating supplement options requires looking beyond marketing terms like "high absorption" or "advanced delivery". The delivery method must be matched to the specific biochemical properties of the molecule:

Natural production of alpha-ketoglutarate declines steadily with age. Choosing a delivery format that keeps the molecule active in your bloodstream ensures your cells receive the continuous support they need to maintain repair pathways, protect DNA, and support long-term vitality.